Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1
- PMID: 8203119
- DOI: 10.1016/0378-1135(94)90094-9
Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1
Abstract
The antibody response to foot-and-mouth disease virus (FMDV) antigens of type Asia-1 in guinea-pigs was studied by micro-serum neutralization test (MSNT) and enzyme-linked immunosorbent assay (ELISA). One inoculation of as little as 1 microgram of binary ethyleneimine (BEI)-inactivated 146S virus particles in guinea-pigs elicited enough neutralizing antibodies to protect them against challenge with virulent virus. However, one inoculation of live 146S virus particles elicited higher levels of neutralizing antibodies in guinea-pigs than that of inactivated 146S particles. One inoculation of 12S protein subunits in guinea-pigs elicited only non-neutralizing anti-12S antibodies detected by ELISA. Similarly, non-neutralizing anti-VP1 antibodies were detected by ELISA after one inoculation of VP1. However, multiple inoculations of 12S or VP1 elicited measurable neutralizing antibodies in guinea-pigs that protected them against challenge.
Similar articles
-
Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1.J Gen Virol. 1982 Dec;63(2):375-81. doi: 10.1099/0022-1317-63-2-375. J Gen Virol. 1982. PMID: 6296284
-
Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.J Gen Virol. 1980 Oct;50(2):369-75. doi: 10.1099/0022-1317-50-2-369. J Gen Virol. 1980. PMID: 6257825
-
Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.Acta Virol. 1987 Mar;31(2):109-15. Acta Virol. 1987. PMID: 2886019
-
Use of peptides for immunization against foot-and-mouth disease.Vaccine. 1988 Apr;6(2):180-2. doi: 10.1016/s0264-410x(88)80024-0. Vaccine. 1988. PMID: 2838987 Review.
-
Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus.Virus Res. 1999 Aug;62(2):169-75. doi: 10.1016/s0168-1702(99)00042-8. Virus Res. 1999. PMID: 10507326 Review.
Cited by
-
Novel Capsid-Specific Single-Domain Antibodies with Broad Foot-and-Mouth Disease Strain Recognition Reveal Differences in Antigenicity of Virions, Empty Capsids, and Virus-Like Particles.Vaccines (Basel). 2021 Jun 8;9(6):620. doi: 10.3390/vaccines9060620. Vaccines (Basel). 2021. PMID: 34201329 Free PMC article.
-
The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine.PLoS One. 2020 May 5;15(5):e0232782. doi: 10.1371/journal.pone.0232782. eCollection 2020. PLoS One. 2020. PMID: 32369529 Free PMC article.
-
Foot-and-mouth disease virus antigenic landscape and reduced immunogenicity elucidated in atomic detail.Nat Commun. 2024 Oct 10;15(1):8774. doi: 10.1038/s41467-024-53027-5. Nat Commun. 2024. PMID: 39389971 Free PMC article.
-
Calcium Chloride as a Novel Stabilizer for Foot-and-Mouth Disease Virus and Its Application in the Vaccine Formulation.Vaccines (Basel). 2024 Mar 29;12(4):367. doi: 10.3390/vaccines12040367. Vaccines (Basel). 2024. PMID: 38675749 Free PMC article.
-
Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control.Front Immunol. 2017 Aug 17;8:960. doi: 10.3389/fimmu.2017.00960. eCollection 2017. Front Immunol. 2017. PMID: 28861080 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources